Association Between Serum Pyridoxal 5′‐Phosphate and Frailty Risk in Community‐Dwelling Older Japanese Adults
Geriatrics & Gerontology International · 2026
DOI: 10.1111/ggi.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geriatrics & Gerontology International, 2026. Verfasst von Maika Ohta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Graduate School of Human Life and Ecology, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: Pyridoxal Phosphate, Frailty, Frail Elderly. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Pyridoxal 5′‐phosphate (PLP) is the coenzyme form of vitamin B 6 . PLP is essential for amino acid metabolism, protein turnover, and neurotransmitter synthesis. Plasma or serum PLP concentration is used as an indicator of vitamin B 6 status. A deficiency in PLP may be a risk factor for frailty. While previous cross‐sectional studies have associated low plasma or serum PLP levels with frailty, this association has not yet been examined in older Japanese adults.
Methods
We analyzed data from 419 community‐dwelling individuals aged ≥ 65 years in Tarumizu City, Kagoshima, Japan. Participants with relevant medical histories, missing data, or extreme values were excluded. Frailty was assessed using J‐CHS criteria. Serum PLP concentrations were divided into quartiles (Q1–Q4). Logistic regression was used to estimate the Odds ratios (ORs) for pre‐frailty/frailty after adjusting for demographic, lifestyle, and clinical factors.
Results
Pre‐frailty/frailty prevalence was 62%, 40%, 57%, and 57% in Q1–Q4, respectively. The proportion of pre‐frailty/frailty was the lowest in Q2. Compared to Q2, adjusted ORs were 1.94 (95% CI: 1.06–3.59; p = 0.033) in Q1, 1.68 (95% CI: 0.93–3.07; p = 0.089) in Q3, and 1.86 (95% CI: 1.01–3.47; p = 0.047) in Q4.
Conclusion
The relationship between PLP levels and pre‐frailty/frailty was found to be non‐linear. The lowest prevalence was observed in Q2, whereas both low and high PLP levels were associated with increased ORs of pre‐frailty/frailty. Further prospective studies are needed to clarify the causal relationship in older Japanese adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, Graduate School of Human Life and Ecology, Osaka Metropolitan University, Osaka, Japan.
- Department of Human Life and Science, Kagoshima Women's College, Kagoshima, Japan.
- Kagoshima Dietetic Association, Kagoshima, Japan.
- Department of Physical Therapy, School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
- Department of Health and Nutrition, Kagoshima Immaculate Heart University, Kagoshima, Japan.
- Tarumizu Municipal Medical Center, Tarumizu Chuo Hospital, Kagoshima, Japan.
ORCID-Profile: Hyuma Makizako, Hiroaki Kanouchi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ohta, M., Kaimoto, K., Makizako, H., Aburada, S., Imamura, K., Manabe, H., Takenaka, T., Kubozono, T., Ohishi, M., Kuwabara, A., & Kanouchi, H. (2026). Association Between Serum Pyridoxal 5′‐Phosphate and Frailty Risk in Community‐Dwelling Older Japanese Adults. Geriatrics & Gerontology International. https://doi.org/10.1111/ggi.70412
Vancouver
Ohta M, Kaimoto K, Makizako H, Aburada S, Imamura K, Manabe H, et al. Association Between Serum Pyridoxal 5′‐Phosphate and Frailty Risk in Community‐Dwelling Older Japanese Adults. Geriatrics & Gerontology International. 2026. doi:10.1111/ggi.70412
BibTeX
@article{Ohta2026,
author = {Ohta, Maika and Kaimoto, Kaori and Makizako, Hyuma and Aburada, Sachiko and Imamura, Kayoko and Manabe, Hisami and Takenaka, Toshihiro and Kubozono, Takuro and Ohishi, Mitsuru and Kuwabara, Akiko and Kanouchi, Hiroaki},
title = {Association Between Serum Pyridoxal 5′‐Phosphate and Frailty Risk in Community‐Dwelling Older Japanese Adults},
journal = {Geriatrics & Gerontology International},
year = {2026},
doi = {10.1111/ggi.70412}
}
EUVIMED